Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
6.66
-0.06 (-0.89%)
Oct 29, 2025, 12:55 PM EDT - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $805.68 million as of October 29, 2025. Its market cap has increased by 80.94% in one year.
Market Cap
805.68M
Enterprise Value
792.66M
1-Year Change
80.94%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $805.68M, an increase of 104.89%. That is a compound annual growth rate of 10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 812.94M | 150.45% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | 179.87M | -3.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |